Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Dec;96(6):2744–2747. doi: 10.1172/JCI118343

Genetic instability in patients with Hodgkin's disease undergoing chemotherapy.

J M Abdallah 1, D P Lombardi 1, I R Kirsch 1
PMCID: PMC185983  PMID: 8675643

Abstract

We have studied the effect of chemotherapy on the level of a particular kind of genetic instability in patients with Hodgkin's disease. The particular type of genetic instability assayed is exemplified by trans-rearrangements between two (rather than within one) T cell antigen receptor. 16 patients were studied during their course of treatment. Presentation samples were available for 13 of these patients; 9 of them showed an increase in the level of trans-rearrangements during their exposure to chemotherapeutic agents (P < 0.043). All patients for whom posttherapy samples were available (10 out of 16) showed a return to baseline levels of trans-rearrangements 1-5 mo after completion of therapy (P < 0.03). Thus, this assay appears to be a marker for the "destabilizing" effects of certain chemotherapeutic agents.

Full text

PDF
2744

Images in this article

2745Image
on p.2745

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ammenheuser M. M., Ward J. B., Jr, Whorton E. B., Jr, Killian J. M., Legator M. S. Elevated frequencies of 6-thioguanine-resistant lymphocytes in multiple sclerosis patients treated with cyclophosphamide: a prospective study. Mutat Res. 1988 Mar;204(3):509–520. doi: 10.1016/0165-1218(88)90045-6. [DOI] [PubMed] [Google Scholar]
  2. Buffone G. J., Darlington G. J. Isolation of DNA from biological specimens without extraction with phenol. Clin Chem. 1985 Jan;31(1):164–165. [PubMed] [Google Scholar]
  3. Caggana M., Liber H. L., Mauch P. M., Coleman C. N., Kelsey K. T. In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients. Environ Mol Mutagen. 1991;18(1):6–13. doi: 10.1002/em.2850180103. [DOI] [PubMed] [Google Scholar]
  4. Hagmar L., Brøgger A., Hansteen I. L., Heim S., Högstedt B., Knudsen L., Lambert B., Linnainmaa K., Mitelman F., Nordenson I. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res. 1994 Jun 1;54(11):2919–2922. [PubMed] [Google Scholar]
  5. Heim S., Johansson B., Mertens F. Constitutional chromosome instability and cancer risk. Mutat Res. 1989 Jul;221(1):39–51. doi: 10.1016/0165-1110(89)90044-4. [DOI] [PubMed] [Google Scholar]
  6. Hsu T. C. Genetic instability in the human population: a working hypothesis. Hereditas. 1983;98(1):1–9. doi: 10.1111/j.1601-5223.1983.tb00574.x. [DOI] [PubMed] [Google Scholar]
  7. Kirsch I. R., Abdallah J. M., Bertness V. L., Hale M., Lipkowitz S., Lista F., Lombardi D. P. Lymphocyte-specific genetic instability and cancer. Cold Spring Harb Symp Quant Biol. 1994;59:287–295. doi: 10.1101/sqb.1994.059.01.033. [DOI] [PubMed] [Google Scholar]
  8. Kirsch I. R., Lipkowitz S. A measure of genomic instability and its relevance to lymphomagenesis. Cancer Res. 1992 Oct 1;52(19 Suppl):5545s–5546s. [PubMed] [Google Scholar]
  9. Lipkowitz S., Garry V. F., Kirsch I. R. Interlocus V-J recombination measures genomic instability in agriculture workers at risk for lymphoid malignancies. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5301–5305. doi: 10.1073/pnas.89.12.5301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lipkowitz S., Stern M. H., Kirsch I. R. Hybrid T cell receptor genes formed by interlocus recombination in normal and ataxia-telangiectasis lymphocytes. J Exp Med. 1990 Aug 1;172(2):409–418. doi: 10.1084/jem.172.2.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mott M. G., Boyse J., Hewitt M., Radford M. Do mutations at the glycophorin A locus in patients treated for childhood Hodgkin's disease predict secondary leukaemia? Lancet. 1994 Apr 2;343(8901):828–829. doi: 10.1016/s0140-6736(94)92027-3. [DOI] [PubMed] [Google Scholar]
  12. Pienta K. J., Ward W. S. An unstable nuclear matrix may contribute to genetic instability. Med Hypotheses. 1994 Jan;42(1):45–52. doi: 10.1016/0306-9877(94)90035-3. [DOI] [PubMed] [Google Scholar]
  13. Tucker M. A., Coleman C. N., Cox R. S., Varghese A., Rosenberg S. A. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med. 1988 Jan 14;318(2):76–81. doi: 10.1056/NEJM198801143180203. [DOI] [PubMed] [Google Scholar]
  14. Weisenburger D. D. Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemic. Ann Oncol. 1994;5 (Suppl 1):19–24. doi: 10.1093/annonc/5.suppl_1.s19. [DOI] [PubMed] [Google Scholar]
  15. van Leeuwen F. E., Klokman W. J., Hagenbeek A., Noyon R., van den Belt-Dusebout A. W., van Kerkhoff E. H., van Heerde P., Somers R. Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol. 1994 Feb;12(2):312–325. doi: 10.1200/JCO.1994.12.2.312. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES